Shanghai Blue Lion Blotechnology Inc
Shanghai Blue Lion Biotechnology Inc is a pharmaceutical manufacturing and export company located in Shanghai, China. The organization positions itself within one of the country’s major financial, shipping, and logistics hubs, leveraging its strategic location to support global trade in active pharmaceutical ingredients (API) and steroid intermediates. The company emphasizes a robust approach to research and development, highlighting significant investment in its R&D department to sustain product quality and a broad product portfolio.
A key feature of Shanghai Blue Lion Biotechnology Inc is its production infrastructure, which comprises four GMP-standard workshops. This production base is complemented by a laboratory equipped with essential facilities to ensure the quality of raw materials and finished products. The company’s portfolio includes major androgenic compounds, with products spanning Boldenone Series, Testosterone Series, Nandrolone Series, Oxymetholone, Stanozolol, and Methandrostenolone. The emphasis on GMP compliance and a well-equipped laboratory indicates a framework designed to maintain high manufacturing standards and consistent product quality.
From a commercial perspective, the company notes a growing customer base and increasing sales volume year over year. It describes its customers as largely loyal, attracted by a combination of product breadth, flexible payment options, fast and insured delivery, a streamlined ordering process, and responsive customer service. The combination of product diversity and customer-centric service is presented as a core strength in maintaining long-term business relationships.
Shanghai Blue Lion Biotechnology Inc also positions itself as a participant in China’s logistics environment, underscoring its accessibility to global markets through Shanghai’s established logistics network. While the company’s stated focus is on the development, production, and export of steroid APIs and intermediates, it also references a commitment to quality and reliability as guiding principles. The organization communicates a forward-looking stance, expressing willingness to establish durable, mutually beneficial relationships with customers worldwide.
In terms of operational philosophy, the company highlights the integration of research, manufacturing, and distribution as a cohesive model aimed at delivering dependable supply and quality assurance. Although the primary emphasis is on pharmaceutical manufacturing, the mention of a “logistics center” and the assertion of insured delivery reflect attention to the end-to-end supply chain and the importance of dependable shipping arrangements for international customers. The company’s profile suggests a framework where technical capability, regulatory compliance, and logistics coordination work in concert to support global customers seeking steroid APIs and related materials.
Because information about regulatory certifications beyond GMP, specific export destinations, or detailed logistics services is not extensively disclosed in the available materials, potential partners and customers may wish to engage directly to obtain further clarification on certification scope, quality management systems, and the full range of logistics offerings. Nevertheless, the combination of GMP-compliant production, a sizable R&D program, a diversified API product line, and a stated customer-oriented logistics approach positions Shanghai Blue Lion Biotechnology Inc as a Chinese supplier capable of supporting international pharmaceutical supply chains within its stated product focus.
This profile draws upon the company’s described capabilities and strategic emphasis as presented in its materials, including its Shanghai base, GMP production facilities, dedicated R&D investment, and a customer-centric approach to order processing and delivery. As the company continues to evolve, potential collaborations and supplier relationships may be informed by its established manufacturing standards, laboratory capabilities, and willingness to sustain long-term business partnerships with global customers.